Keith Michael Gottesdiener, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), bought 1,171 shares at $64.00 ($75K) on 2018-04-09, disclosed to the SEC on 2018-04-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| RYTM | SELL | 2019-02-28 | $128K | — | Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |